Turning Point Brands (NYSE: TPB) reported Q1 EPS of $0.91, $0.20 better than the analyst estimate of $0.71. Revenue for the quarter came in at $106.4 million versus the consensus estimate of $92.53 million.

2025 Outlook

The Company is increasing projected Modern Oral sales from $60.0 – 80.0 million to $80.0 – 95.0 million.

The Company is maintaining its previous expectation for full-year 2025 adjusted EBITDA of $108.0 – 113.0 million.

For earnings history and earnings-related data on Turning Point Brands (TPB) click here.